Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1975 8
1976 12
1977 38
1978 45
1979 46
1980 42
1981 49
1982 48
1983 56
1984 63
1985 95
1986 93
1987 91
1988 111
1989 129
1990 145
1991 148
1992 146
1993 209
1994 189
1995 217
1996 225
1997 231
1998 245
1999 277
2000 274
2001 319
2002 348
2003 377
2004 439
2005 420
2006 476
2007 497
2008 490
2009 505
2010 590
2011 593
2012 634
2013 707
2014 731
2015 732
2016 787
2017 765
2018 769
2019 779
2020 866
2021 837
2022 758
2023 75
Text availability
Article attribute
Article type
Publication date

Search Results

14,963 results
Results by year
Filters applied: . Clear all
Page 1
Diclofenac sodium.
Small RE. Small RE. Clin Pharm. 1989 Aug;8(8):545-58. Clin Pharm. 1989. PMID: 2670397 Review.
Diclofenac was as effective as indomethacin or sulindac in treating ankylosing spondylitis. The most frequent adverse effects reported for diclofenac were gastrointestinal, but these effects were fewer and less serious than occurred with aspirin or indomethacin; in
Diclofenac was as effective as indomethacin or sulindac in treating ankylosing spondylitis. The most frequent adverse effects reporte
Diclofenac: an update on its mechanism of action and safety profile.
Gan TJ. Gan TJ. Curr Med Res Opin. 2010 Jul;26(7):1715-31. doi: 10.1185/03007995.2010.486301. Curr Med Res Opin. 2010. PMID: 20470236 Review.
As with all NSAIDs, diclofenac exerts its action via inhibition of prostaglandin synthesis by inhibiting cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) with relative equipotency. ...The diversity in diclofenac's MOA may suggest the potential for a relatively …
As with all NSAIDs, diclofenac exerts its action via inhibition of prostaglandin synthesis by inhibiting cyclooxygenase-1 (COX-1) and …
Oral Versus Topical Diclofenac Sodium in the Treatment of Osteoarthritis.
Tieppo Francio V, Davani S, Towery C, Brown TL. Tieppo Francio V, et al. J Pain Palliat Care Pharmacother. 2017 Jun;31(2):113-120. doi: 10.1080/15360288.2017.1301616. Epub 2017 Apr 7. J Pain Palliat Care Pharmacother. 2017. PMID: 28388238 Review.
Generally, oral NSAIDs are well tolerated; however our narrative review suggests that the topical solution had a better tolerability property than oral Diclofenac sodium, especially due to side effects of gastrointestinal bleeding with the utilization of the oral format. . …
Generally, oral NSAIDs are well tolerated; however our narrative review suggests that the topical solution had a better tolerability propert …
Lumiracoxib.
Buvanendran A, Barkin R. Buvanendran A, et al. Drugs Today (Barc). 2007 Mar;43(3):137-47. doi: 10.1358/dot.2007.43.3.1062673. Drugs Today (Barc). 2007. PMID: 17380211 Review.
Diclofenac.
Ogle C. Ogle C. Conn Med. 1989 Oct;53(10):603-4. Conn Med. 1989. PMID: 2684502 Clinical Trial.
Diclofenac is the newest NSAID to be introduced to the United States. Extensive worldwide clinical studies with diclofenac have demonstrated its efficacy in the treatment of rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. ...
Diclofenac is the newest NSAID to be introduced to the United States. Extensive worldwide clinical studies with diclofenac hav
Diclofenac sodium injection (Dyloject): in postoperative pain.
McCormack PL, Scott LJ. McCormack PL, et al. Drugs. 2008;68(1):123-30. doi: 10.2165/00003495-200868010-00008. Drugs. 2008. PMID: 18081376 Review.
*A new formulation of the nonselective NSAID diclofenac sodium suitable for intravenous bolus injection has been developed using hydroxypropyl beta-cyclodextrin as a solubility enhancer (HPbetaCD diclofenac). * HPbetaCD diclofenac intravenous bolus injection …
*A new formulation of the nonselective NSAID diclofenac sodium suitable for intravenous bolus injection has been developed using hydr …
[Voltaren--the gold standard].
Babić-Naglić D. Babić-Naglić D. Reumatizam. 2000;47(2):29-31. Reumatizam. 2000. PMID: 11552612 Review. Croatian.
In this article the advantages and the faults of diclofenac are described with short review of pharmacodynamic and pharmacokinetic properties and results of the recent clinical trials. ...
In this article the advantages and the faults of diclofenac are described with short review of pharmacodynamic and pharmacokinetic pr …
Diclofenac epolamine (Flector) patch: evidence for topical activity.
Petersen B, Rovati S. Petersen B, et al. Clin Drug Investig. 2009;29(1):1-9. doi: 10.2165/0044011-200929010-00001. Clin Drug Investig. 2009. PMID: 19067470 Review.
This review focuses on previously unpublished clinical and pharmacokinetic data with the diclofenac epolamine (diclofenac hydroxyethylpyrrolidine) patch supporting the hypothesis of a topical effect of this formulation. ...Hence, the patch provided pain relief at a …
This review focuses on previously unpublished clinical and pharmacokinetic data with the diclofenac epolamine (diclofenac hydr …
Biopharmaceutical profile of diclofenac-misoprostol combination tablet, Arthrotec.
Karim A, Smith M. Karim A, et al. Scand J Rheumatol Suppl. 1992;96:37-48. doi: 10.3109/03009749209095098. Scand J Rheumatol Suppl. 1992. PMID: 1439623 Review.
Arthrotec, a combination tablet has been developed that contains 50 mg of diclofenac in an inner core and 200 micrograms of misoprostol in an outer mantle. ...No pharmacokinetic interactions between diclofenac and misoprostol were apparent. The bioavailability of …
Arthrotec, a combination tablet has been developed that contains 50 mg of diclofenac in an inner core and 200 micrograms of misoprost …
Synthesis and anti-phlogistic potency of some new non-proteinogenic amino acid conjugates of "Diclofenac".
Abo-Ghalia MH, Shalaby AM, el-Eraqi WI, Awad HM. Abo-Ghalia MH, et al. Amino Acids. 1999;16(3-4):425-40. doi: 10.1007/BF01388181. Amino Acids. 1999. PMID: 10399025 Review.
"Diclofenac" amino acid esters (IIa-d), were synthesized via the corresponding HOSu or HOBt active esters. ...Further, they considerably retained a generalized anti-phlogistic activity. The major "Diclofenac" irritating gastric side effect was thus eliminated. Parti …
"Diclofenac" amino acid esters (IIa-d), were synthesized via the corresponding HOSu or HOBt active esters. ...Further, they considera …
14,963 results
You have reached the last available page of results. Please see the User Guide for more information.